{"id":3380,"date":"2025-11-01T21:33:27","date_gmt":"2025-11-01T12:33:27","guid":{"rendered":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/?p=3380"},"modified":"2025-11-01T21:33:27","modified_gmt":"2025-11-01T12:33:27","slug":"%e7%b7%9a%e7%b6%ad%e8%8a%bd%e7%b4%b0%e8%83%9e%e6%b4%bb%e6%80%a7%e5%8c%96%e3%82%bf%e3%83%b3%e3%83%91%e3%82%af%e8%b3%aafap%e6%a8%99%e7%9a%84%e6%94%be%e5%b0%84%e6%80%a7%e8%96%ac%e5%89%a4%e3%81%ae","status":"publish","type":"post","link":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/2025-11-01-3380\/","title":{"rendered":"\u7dda\u7dad\u82bd\u7d30\u80de\u6d3b\u6027\u5316\u30bf\u30f3\u30d1\u30af\u8cea(FAP)\u6a19\u7684\u653e\u5c04\u6027\u85ac\u5264\u306e\u304c\u3093\u96c6\u7a4d\u5411\u4e0a\u306b\u8cc7\u3059\u308b\u65b0\u898f\uff12\u4fa1\u30a2\u30eb\u30d6\u30df\u30f3\u30d0\u30a4\u30f3\u30c0\u30fc\u306e\u958b\u767a\u306b\u95a2\u3059\u308b\u8ad6\u6587\u304c\u3001Chemical Communications\u8a8c\u306b\u53d7\u7406\u3055\u308c\u307e\u3057\u305f\u3002"},"content":{"rendered":"<p>\u7dda\u7dad\u82bd\u7d30\u80de\u6d3b\u6027\u5316\u30bf\u30f3\u30d1\u30af\u8cea(FAP)\u6a19\u7684\u653e\u5c04\u6027\u85ac\u5264\u306e\u304c\u3093\u96c6\u7a4d\u5411\u4e0a\u306b\u8cc7\u3059\u308b\u65b0\u898f\uff12\u4fa1\u30a2\u30eb\u30d6\u30df\u30f3\u30d0\u30a4\u30f3\u30c0\u30fc\u306e\u958b\u767a\u306b\u95a2\u3059\u308b\u8ad6\u6587\u304c\u3001Chemical Communications\u8a8c\u306b\u53d7\u7406\u3055\u308c\u307e\u3057\u305f\u3002<\/p>\n<ul>\n<li>Novel bivalent albumin binder for enhanced tumor retention of fibroblast activation protein-targeted radioligand (Nakashima K, Yamaguchi K, Ono M, et al.)<\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>\u7dda\u7dad\u82bd\u7d30\u80de\u6d3b\u6027\u5316\u30bf\u30f3\u30d1\u30af\u8cea(FAP)\u6a19\u7684\u653e\u5c04\u6027\u85ac\u5264\u306e\u304c\u3093\u96c6\u7a4d\u5411\u4e0a\u306b\u8cc7\u3059\u308b\u65b0\u898f\uff12\u4fa1\u30a2\u30eb\u30d6\u30df\u30f3\u30d0\u30a4\u30f3\u30c0\u30fc\u306e\u958b\u767a\u306b\u95a2\u3059\u308b\u8ad6\u6587\u304c\u3001Chemical Communications\u8a8c\u306b\u53d7\u7406\u3055\u308c\u307e\u3057\u305f\u3002 Novel bivalent  [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_crdt_document":"","footnotes":""},"categories":[3],"tags":[],"class_list":["post-3380","post","type-post","status-publish","format-standard","hentry","category-info"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/posts\/3380","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/comments?post=3380"}],"version-history":[{"count":2,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/posts\/3380\/revisions"}],"predecessor-version":[{"id":3383,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/posts\/3380\/revisions\/3383"}],"wp:attachment":[{"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/media?parent=3380"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/categories?post=3380"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharm.kyoto-u.ac.jp\/byotai\/wp-json\/wp\/v2\/tags?post=3380"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}